Login / Signup

Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey.

Vittorio PengoTeresa Del RossMarta TonelloLaura AndreoliAngela TincaniPaolo GreseleElena SilvestriPaolo SimioniElena CampelloAriela HoxhaAnna FalangaAngelo GhirarduzziGentian Denasnull null
Published in: Rheumatology (Oxford, England) (2022)
Patients with triple-positive thrombotic APS did not suffer from severe COVID-19 outcomes. Importantly, COVID-19 vaccination was well tolerated. These data may reassure patients and physicians and contribute to reducing hesitancy in unvaccinated patients.
Keyphrases